Literature DB >> 6585368

New avian model of experimental glomerulonephritis consistent with mediation by cellular immunity. Nonhumorally mediated glomerulonephritis in chickens.

W K Bolton, F L Tucker, B C Sturgill.   

Abstract

The present study examined the role of cell-mediated immunity (CMI) in the production of experimental autoimmune glomerulonephritis (EAG) in chickens deficient in humorally mediated immunity (HMI). Cyclophosphamide bursectomized (Bsx) and normal control chickens were used. Bsx chickens were used only if they had severe depression of HMI, which was evidenced by marked reduction in bursal weights (0.89 +/- 0.23 vs. 2.92 +/- 0.9 g), decreased serum IgG to less than or equal to 10% of normal, and total lack of HMI to immunization with sheep red blood cells. EAG was produced by immunizing chickens with bovine glomerular basement membrane (GBM) in complete Freund's adjuvant. CMI manifested by wattle thickness increments to PPD was not different, 3.89 +/- 0.45 mm for Bsx compared with 3.73 +/- 0.75 mm for controls. No circulating antibodies to GBM developed in 68% of Bsx chickens, and the anti-GBM titers were less than 1:312 in those Bsx chickens positive for antibody compared with greater than 2,000 for controls. GBM deposits of IgG by fluorescence were much decreased, 0.53 +/- 0.16 compared with 2.19 +/- 0.32 for controls, and were absent in 64% of Bsx chickens. Nonetheless, proliferative nephritis with crescents was present and was even more severe in Bsx chickens than in controls, with glomerular sizes of 20.8 +/- 0.6 U for Bsx-GBM, 19.8 +/- 1.2 for control-GBM, 14.9 +/- 1.5 for Bsx, and 13.6 +/- 0.8 for normal chickens. Nephritic eluates did not produce disease in normal chickens, while administration of sensitized cells with [H3]thymidine to naive birds was associated with increased mesangial grain counts by autoradiography. These findings suggest that CMI plays a major role in the pathogenesis of EAG in chickens in the absence of HMI. By implication, CMI may be crucial in the development of other types of glomerulonephritis as well.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6585368      PMCID: PMC425147          DOI: 10.1172/JCI111328

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  Peroxidaseless chicken leukocytes: isolation and characterization of antibacterial granules.

Authors:  K Brune; J K Spitznagel
Journal:  J Infect Dis       Date:  1973-01       Impact factor: 5.226

2.  The effect of cyclophosphamide on the ontogeny of the humoral immune response in chickens.

Authors:  S P Lerman; W P Weidanz
Journal:  J Immunol       Date:  1970-09       Impact factor: 5.422

3.  Effects of early cyclophosphamide treatment on the development of lymphoid organs and immunological functions in the chickens.

Authors:  T J Linna; D Frommel; R A Good
Journal:  Int Arch Allergy Appl Immunol       Date:  1972

4.  Detection of humoral and cell-mediated immunity to kidney basement membranes in human renal diseases.

Authors:  P Mahieu; M Dardenne; J F Bach
Journal:  Am J Med       Date:  1972-08       Impact factor: 4.965

5.  Alllergic response to glomerular basement membrane in patients with glomerulonephritis.

Authors:  M Macanovic; D J Evans; D K Peters
Journal:  Lancet       Date:  1972-07-29       Impact factor: 79.321

6.  In vitro evidence for cellular hypersensitivity to glomerular-basement-membrane antigens in human glomerulonephritis.

Authors:  R E Rocklin; E J Lewis; J R David
Journal:  N Engl J Med       Date:  1970-09-03       Impact factor: 91.245

7.  Organ-specific inhibition of the in vitro migration of leucocytes in human glomerulonephritis.

Authors:  G Bendixen
Journal:  Acta Med Scand       Date:  1968 Jul-Aug

8.  Lymphocytic responses to streptococcal antigens in glomerulonephritic patients.

Authors:  J B Zabriskie; R Lewshenia; G Möller; B Wehle; R E Falk
Journal:  Science       Date:  1970-05-29       Impact factor: 47.728

9.  What are sensitized cells doing in glomerulonephritis?

Authors:  F J Dixon
Journal:  N Engl J Med       Date:  1970-09-03       Impact factor: 91.245

10.  Transfer of ovine experimental allergic glomerulonephritis (EAG) with serum.

Authors:  R A Lerner; F J Dixon
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

View more
  22 in total

1.  CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis.

Authors:  Jean Wu; John Hicks; Jason Borillo; William F Glass; Ya-Huan Lou
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

2.  What sensitized cells just might be doing in glomerulonephritis.

Authors:  W Kline Bolton
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  Genetic elimination of α3(IV) collagen fails to rescue anti-collagen B cells.

Authors:  Amy G Clark; Katherine M Mackin; Mary H Foster
Journal:  Immunol Lett       Date:  2011-09-24       Impact factor: 3.685

Review 4.  The role of anti-DNA antibodies in lupus nephritis.

Authors:  M Waer
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

5.  Analysis of T cells and major histocompatibility complex class I and class II mRNA and protein content and distribution in antiglomerular basement membrane disease in the rabbit.

Authors:  C Eldredge; S Merritt; M Goyal; H Kulaga; T J Kindt; R Wiggins
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

Review 6.  Basement membranes and autoimmune diseases.

Authors:  Mary H Foster
Journal:  Matrix Biol       Date:  2016-08-02       Impact factor: 11.583

Review 7.  Update on crescentic glomerulonephritis.

Authors:  Carole Hénique; Christina Papista; Léa Guyonnet; Olivia Lenoir; Pierre-Louis Tharaux
Journal:  Semin Immunopathol       Date:  2014-06-20       Impact factor: 9.623

8.  Hapten-specific cellular immune response producing glomerular injury.

Authors:  T Oite; F Shimizu; S Kagami; T Morioka
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

Review 9.  Goodpasture's autoimmune disease - A collagen IV disorder.

Authors:  Vadim Pedchenko; A Richard Kitching; Billy G Hudson
Journal:  Matrix Biol       Date:  2018-05-12       Impact factor: 11.583

10.  WY14,643, a PPARalpha ligand, attenuates expression of anti-glomerular basement membrane disease.

Authors:  D C Archer; J T Frkanec; J Cromwell; P Clopton; R Cunard
Journal:  Clin Exp Immunol       Date:  2007-09-20       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.